ISSN (Print):
2212-697X
ISSN (Online):
2212-6988
Download PDF Flyer

Clinical Cancer Drugs

Volume 11 , 2025


Institutional Members

Limited-Time Complimentary Open Access Offer Get free Open Access by submitting your article on or before July 31st, 2025. This offer applies to general articles only.

Topic(s) Covered

1 Topic(s)

View
Covered Disease(s)

1 Disease(s)

View

Aims & Scope

Clinical Cancer Drugs publishes original research, expert reviews, and thematic issues covering all core areas of translational and clinical cancer drug research.

The journal publishes pre-clinical and clinical studies on the development of new anti-cancer agents. Clinical studies of new reported anti-cancer drugs include Phase 1–IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading to clinical oncologists, toxicologists, medicinal chemists, and pharmacologist.

Clinical Cancer Drugs is an international, peer-reviewed journal on all aspects of cancer drugs published continuously (print & online) by Bentham Science Publishers.
Special Offers

30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published.
Multiple issue copies at discounted rates.

Announcements
© 2025 Bentham Science Publishers | Privacy Policy